Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: airtight package for oversea shipment
Transportation: Ocean,Land,Air,Express
Supply Ability: 5000kgs monthly
Port: BEIJING,SHANGHAI,QINGDAO
E7080 Mesylate is a multi-target tyrosine kinase inhibitor developed by Eisai Japan. It has a novel binding mode. In addition to inhibiting other pro-angiogenesis and oncogenic signaling pathway-related tyrosine kinases involved in tumor proliferation, it can also selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptors, such as VEGF-1, VEGF-2 and VEGF- 3 and so on.
PRODUCT E7080 Mesylate
CAS 857890-39-2
MF C21H19ClN4O4
MW 426.85
Product Categories : API Intermediates > Lenvatinib Mesylate Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.